In 2023, the actual sales of Modulators of the Genital System and Sex Hormones in Austria stood at 12.8 million USD. Forecasted data from 2024 to 2028 shows a steady decline, with values projected to be 12.6 million USD in 2024, gradually decreasing to 11.8 million USD by 2028. This represents a year-on-year percentage decline of 1.41% in 2025, 0.81% in 2026, 1.64% in 2027, and 1.67% in 2028. Over the forecasted period, the Compound Annual Growth Rate (CAGR) is approximately -1.52%.
Future trends to watch for include possible advancements in alternative treatments, shifts in population demographics, and regulatory changes that could impact market dynamics. Monitoring these factors will be crucial in understanding their potential influence on market fluctuations.
